This site is intended for UK healthcare professionals only
Source: BMJ Sexual & Reproductive Health
The levonorgestrel-releasing intrauterine system (LNG-IUS) first became available in 1990 with the introduction of Mirena (LNG-IUS 20). Over the past 30 years, the impact of the LNG-IUS on society has been wide ranging, including decreasing the need for abortion, reducing the number of surgical sterilisation procedures performed, as well as reducing the number of hysterectomies carried out for issues such as heavy menstrual bleeding (HMB).
We do not endorse, approve, certify, or control any linked websites, their sponsors, or any of their policies, activities, products, or services. We do not assume responsibility for the accuracy, completeness, or timeliness of the information.
Visitors to any linked websites should not use or rely on the information contained therein.
Please click “Continue” to leave this website and proceed to the selected site.
This link takes you to a 3rd party website not controlled by us.
The site may contain information that has been created, published, maintained, or posted by institutions or organisations independent of the PCWHF.
We do not endorse, approve, certify, or control any linked websites, their sponsors, or any of their policies, activities, products, or services. We do not assume responsibility for the accuracy, completeness, or timeliness of the information.
Visitors to any linked websites should not use or rely on the information contained therein.
Please click “Continue” to leave this website and proceed to the selected site.
